The analysis, conducted by researchers from the University of Oxford and supported by the National Institute for Health Research (NIHR) Oxford Health Biomedical Research Centre and the Medical Research Council, revealed that taking the drug, a popular medication for type II diabetes, had no increased risk of adverse neurological or psychiatric outcomes compared to other antidiabetic medications, challenging recent concerns about the drugs safety
ESPAOL
muciniphila has attracted attention in recent years for its role in the potential amelioration of metabolic diseases
TGF-beta signaling in fibroblasts modulates the oncogenic potential of adjacent epithelia
First, the number of RCTs available for analysis was limited, thus precluding any formal statistical assessment for publication bias, such as funnel plot analysis
beyond 12 hours at room temperature, degradation can exceed 2530%